Daniel Garafola

544 total citations · 1 hit paper
6 papers, 412 citations indexed

About

Daniel Garafola is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daniel Garafola has authored 6 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Daniel Garafola's work include Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers) and interferon and immune responses (2 papers). Daniel Garafola is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers) and interferon and immune responses (2 papers). Daniel Garafola collaborates with scholars based in United States. Daniel Garafola's co-authors include Darrell J. Irvine, Nikki Thai, Naveen K. Mehta, Jason Y.H. Chang, Leyuan Ma, Michael Fichter, K. Dane Wittrup, Sudha Kumari, Simon Liang and Wuhbet Abraham and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Frontiers in Immunology.

In The Last Decade

Daniel Garafola

6 papers receiving 404 citations

Hit Papers

Enhanced CAR–T cell activity against solid tumors by vacc... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Garafola United States 6 262 237 149 115 57 6 412
Benjamin Cossette United States 6 243 0.9× 219 0.9× 146 1.0× 125 1.1× 54 0.9× 7 429
Αndroulla N. Miliotou Greece 8 231 0.9× 146 0.6× 177 1.2× 76 0.7× 75 1.3× 21 452
Simon Liang United States 5 279 1.1× 301 1.3× 221 1.5× 128 1.1× 57 1.0× 7 521
Caleb R. Perez United States 5 257 1.0× 350 1.5× 226 1.5× 119 1.0× 31 0.5× 7 512
Yash Agarwal United States 9 134 0.5× 172 0.7× 142 1.0× 68 0.6× 29 0.5× 12 333
Francesco Nannini United Kingdom 6 188 0.7× 123 0.5× 111 0.7× 76 0.7× 59 1.0× 8 327
Gray Kueberuwa United Kingdom 10 305 1.2× 153 0.6× 133 0.9× 95 0.8× 138 2.4× 22 397
Nathanael J. Bangayan United States 8 266 1.0× 129 0.5× 155 1.0× 113 1.0× 55 1.0× 10 476
Erica M. Gomes United States 7 379 1.4× 204 0.9× 144 1.0× 100 0.9× 148 2.6× 12 485
Fengzhen Mo China 15 228 0.9× 223 0.9× 217 1.5× 125 1.1× 30 0.5× 22 490

Countries citing papers authored by Daniel Garafola

Since Specialization
Citations

This map shows the geographic impact of Daniel Garafola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Garafola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Garafola more than expected).

Fields of papers citing papers by Daniel Garafola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Garafola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Garafola. The network helps show where Daniel Garafola may publish in the future.

Co-authorship network of co-authors of Daniel Garafola

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Garafola. A scholar is included among the top collaborators of Daniel Garafola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Garafola. Daniel Garafola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Backlund, Coralie M., Duncan M. Morgan, Byong H. Kang, et al.. (2022). Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine Melanoma. Frontiers in Immunology. 13. 886683–886683. 12 indexed citations
2.
Backlund, Coralie M., Rebecca L. Holden, Kelly D. Moynihan, et al.. (2022). Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity. Proceedings of the National Academy of Sciences. 119(32). e2204078119–e2204078119. 36 indexed citations
3.
Milling, Lauren E., Daniel Garafola, Yash Agarwal, et al.. (2022). Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation.. Cancer Immunology Research. 10(1). 26–39. 14 indexed citations
4.
Milling, Lauren E., Daniel Garafola, Yash Agarwal, et al.. (2021). Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation. Cancer Immunology Research. 10(1). 26–39. 24 indexed citations
5.
Loftis, Alexander R., Coralie M. Backlund, Anthony J. Quartararo, et al.. (2021). An in vivo selection-derived d -peptide for engineering erythrocyte-binding antigens that promote immune tolerance. Proceedings of the National Academy of Sciences. 118(34). 7 indexed citations
6.
Ma, Leyuan, Tanmay Dichwalkar, Jason Y.H. Chang, et al.. (2019). Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science. 365(6449). 162–168. 319 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026